Search results
4 Analysts Assess Teva Pharmaceutical Indus: What You Need To Know - Teva Pharmaceutical Indus...
Benzinga· 4 days agoDebt Management: With a high debt-to-equity ratio of 2.74 , Teva Pharmaceutical Indus faces challenges in effectively managing its debt levels, indicating potential financial ...
Insider Selling: Director DEVINE MICHAEL F III Sells Shares of Deckers Outdoor Corp (DECK) By...
Investing.com· 5 days agoOn May 29, 2024, DEVINE MICHAEL F III, Director at Deckers Outdoor Corp (NYSE:DECK), executed a sale...
Insider Sale: Director Maha Ibrahim Sells Shares of Deckers Outd
Guru Focus· 5 days agoThe transaction was documented in an SEC Filing. Following this transaction, the insider now owns 1,602 shares of the company. Deckers Outdoor Corp (DECK, Financial) is a global leader in designing ...
Market Whales and Their Recent Bets on DECK Options - Deckers Outdoor (NYSE:DECK)
Benzinga· 12 hours agoFollowing...Trading volume stands at 80,225, with DECK's price down by -0.66%, positioned at $1086.71. RSI indicators show the stock to be may be overbought. Earnings announcement ...
Exploring Three Growth Companies With High Insider Ownership On Euronext Paris
Simply Wall St. via Yahoo Finance· 4 days agoAs global markets navigate through varying performances, with the pan-European STOXX Europe 600...
Heard on the Street Friday Recap: Summer Vibes
The Wall Street Journal· 7 days agoJust in time for summer, a company selling sandals lead the market ahead of Memorial Day weekend. Deckers Outdoor shares jumped more than 14% on Friday,...
Assertio names Brendan O'Grady as new CEO By Investing.com
Investing.com· 5 days agoAssertio Holdings, Inc. (NASDAQ:ASRT), a commercial pharmaceutical company, announced today the...
NurExone Reports First Quarter 2024 Financial Results and Provides Corporate Update, moving forward...
Digital Journal· 6 days agoNurExone Biologic Inc. (TSXV: NRX) (OTCQB: NRXBF) (Germany: J90) (the “Company” or “NurExone”), a pioneering biopharmaceutical company developing regenerative medicine therapies, is pleased ...